- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01153594
Early Re-Intervention Experiment 2 (ERI2)
Early Re-Intervention (ERI) Experiment 2
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
CONTEXT: While drug abuse is the 10th leading cause of mortality in the US, the disorder remains an orphan of the public health care system. Unlike cancer, diabetes, and other chronic diseases, the detection, re-emergence, and progression of which we have learned to respond with aggressively timed monitoring and interventions, drug abuse remains isolated from adoption into the "chronic condition" model of care.
OBJECTIVES AND HYPOTHESES: The objective of this study was to evaluate the relative effectiveness of quarterly checkups on long-term outcomes of adult chronic substance users over 4 years. Relative to participants randomly assigned to the control group, we predicted that RMC participants would: H1) return to treatment sooner, H2) receive more treatment, H3) decrease substance use, and H4) increase days of abstinence.
METHOD: Participants were recruited from sequential intakes at the largest addiction treatment agency in Illinois between February and April of 2004. Inclusion criteria were: any substance use in the past 90 days and any past-year symptoms of substance use disorders. For logistical reasons, participants were excluded if they were: under 18, lived or planned to move outside Chicago within 12 months, sentenced to a confined environment most of the next 12 months, mandated to treatment because of a driving under the influence offense, were not fluent in English or Spanish, or were cognitively unable to provide informed consent. To evaluate efficacy of quarterly Recovery Management Checkups (RMC) on treatment reentry and substance use, 446 adults (88% with dependence criteria) were randomly assigned quarterly RMCs, or, an outcome monitoring only control group and followed quarterly for 4 years (94% completion).
INTERVENTION. After interviewers completed the quarterly research interview and determined participants' eligibility and need for early re-intervention, they transferred RMC participants who were eligible and in need to a Linkage Manager. Using motivational interviewing, the Linkage Manager: a) provided feedback to participants regarding their current substance use and related problems, b) discussed implications of managing addiction as a chronic condition, c) discussed treatment barriers and solutions, d) assessed and discussed level of motivation for treatment, e) scheduled treatment appointments, f) accompanied participants to treatment intake and stayed through the process, and g) implemented Engagement and Retention Protocol during the 14 days of treatment. Detailed procedures and forms are available in the RMC manual(Scott & Dennis, 2003; http://www.chestnut.org/LI/downloads/Scott_&_Dennis_2003_RMC_Manual-2_25_03.pdf ).
OUTCOME MEASURES: Days to first treatment, days of treatment, successive quarters of needing treatment, number of substance problem months, days of abstinence.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60610
- Chestnut Health Systems
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- any substance use in the past 90 days
- any past-year symptoms of substance use disorders.
Exclusion Criteria:
- under 18
- lived or planned to move outside Chicago within 12 months
- sentenced to a confined environment most of the next 12 months
- mandated to treatment because of a driving under the influence offense
- were not fluent in English or Spanish
- were cognitively unable to provide informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Recovery Management Checkups (RMC)
Participants in the RMC group are interviewed quarterly.
When they were found to be in need of treatment, the participant was transferred from the interviewer to a linkage manager to receive the intervention (described next).
They were also able to re-enter treatment on their own and naturally cycle through multiple periods of substance use, treatment, incarceration and recovery.
|
After interviewers completed the quarterly research interview and determined participants' eligibility and need for early re-intervention, they transferred RMC participants who were eligible and in need to a Linkage Manager.
Using motivational interviewing, the Linkage Manager: a) provided feedback to participants regarding their current substance use and related problems, b) discussed implications of managing addiction as a chronic condition, c) discussed treatment barriers and solutions, d) assessed and discussed level of motivation for treatment, e) scheduled treatment appointments, f) accompanied participants to treatment intake and stayed through the process, and g) implemented Engagement and Retention Protocol during the 14 days of treatment
|
|
No Intervention: Control Group
Participants in the control group are interviewed quarterly.
While they do not receive any active intervention from the research team, they are able to re-enter treatment on their own and naturally cycle through multiple periods of substance use, treatment, incarceration and recovery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to First Alcohol or Drug Treatment Re-Entry
Time Frame: Quarterly from random assignment until month 48
|
Days to readmission was calculated as the number of days from the date of the quarterly follow-up interview where the client first reported being in need of treatment (see below) to the date of the first subsequent intake to alcohol or other drug treatment following that interview.
|
Quarterly from random assignment until month 48
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Any Treatment Re-Entry
Time Frame: Quarterly from random assignment until month 48
|
Whether the person re-entered treatment between the point of randomization (at 3 months) and last observation.
|
Quarterly from random assignment until month 48
|
|
Times Re-entered Treatment Time Frame
Time Frame: Quarterly from random assignment until month 48 Description:
|
Number of times client re-entered treatment between randomization and the last observation.
|
Quarterly from random assignment until month 48 Description:
|
|
Total Days of Treatment
Time Frame: Quarterly from random assignment until month 48
|
Based on the sum of days an individual received outpatient, intensive outpatient, residential, or inpatient treatment reported at each interview for a given period.
|
Quarterly from random assignment until month 48
|
|
Quarters with 7 days Outpatient or 14 days Residential
Time Frame: Quarterly from random assignment until month 48
|
The number of quarters a participant received treatment at least 7 days of outpatient or 14 days of residential treatment, regardless of whether it is due to retention, step down or readmission.
|
Quarterly from random assignment until month 48
|
|
Quarters Needing Treatment
Time Frame: Quarterly from random assignment until month 48
|
Defined as a participant living in the community (vs. in incarcerated) who was not already in treatment and had been intoxicated or used alcohol or drugs on 13 or more of the past 90 days; had any symptoms of abuse, dependence, or withdrawal in the past month; or currently felt the need to return to treatment.
Within quarter these criteria for need are internally consistent (alpha=.85)
and the average person in need endorsed 3.3 of 6 of the items (80% endorsed 2 or more).
|
Quarterly from random assignment until month 48
|
|
Successive Quarters Needing Treatment
Time Frame: Quarterly from random assignment until month 48
|
The number of quarters in which the individual started and ended the period "in need of treatment" (see definition above) where missing data were replaced with status at prior wave.
|
Quarterly from random assignment until month 48
|
|
Substance Problem x Months
Time Frame: Quarterly from random assignment until month 48
|
Count of 16 past-month item related to weekly use, hiding using, complaints about use, 4 symptoms of abuse, 7 symptoms of dependence, substance induced health or mental health asked for the month before each quarterly interview times 3 and summed over observations; using mean score for any missing observations.
|
Quarterly from random assignment until month 48
|
|
Total Days of Abstinence
Time Frame: Quarterly from random assignment until month 48
|
Sum of days abstinent from alcohol or other drugs in months 4 to 48 (max=1350 days); using the mean days per quarter for any missing observations.
|
Quarterly from random assignment until month 48
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Christy K Scott, Ph.D., Chestnut Health Systems
- Principal Investigator: Michael L Dennis, Ph.D., Chestnut Health Systems
Publications and helpful links
General Publications
- Dennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007 Dec;4(1):45-55. doi: 10.1151/ascp074145.
- Scott CK, Sonis J, Creamer M, Dennis ML. Maximizing follow-up in longitudinal studies of traumatized populations. J Trauma Stress. 2006 Dec;19(6):757-69. doi: 10.1002/jts.20186.
- Rush BR, Dennis ML, Scott CK, Castel S, Funk RR. The interaction of co-occurring mental disorders and recovery management checkups on substance abuse treatment participation and recovery. Eval Rev. 2008 Feb;32(1):7-38. doi: 10.1177/0193841X07307532.
- Scott CK, Dennis ML. Results from two randomized clinical trials evaluating the impact of quarterly recovery management checkups with adult chronic substance users. Addiction. 2009 Jun;104(6):959-71. doi: 10.1111/j.1360-0443.2009.02525.x. Epub 2009 Mar 13.
- Scott, C.K. Dennis, M.L. (in press). Recovery Management Checkups with adult chronic substance users. In Kelly, J.F., and White, W.L. (Eds), Addiction Recovery Management: Theory, Research, and Practice. New York, NY: Springer
- McCollister KE, French MT, Freitas DM, Dennis ML, Scott CK, Funk RR. Cost-effectiveness analysis of Recovery Management Checkups (RMC) for adults with chronic substance use disorders: evidence from a 4-year randomized trial. Addiction. 2013 Dec;108(12):2166-74. doi: 10.1111/add.12335. Epub 2013 Oct 9.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ERI-2
- 5R37DA011323 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)CompletedSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
University of Illinois at ChicagoNot yet recruitingHealthy | Cannabis Use | Substance Use Disorder (SUD)United States
-
Spark Biomedical, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baylor College... and other collaboratorsRecruitingSubstance Use Disorders | Alcohol Use Disorder | Alcohol Abuse | Substance Use Disorders Alcohol Use Withdrawal StateUnited States
Clinical Trials on Recovery Management Checkups (RMC)
-
Chestnut Health SystemsActive, not recruitingOpioid-use DisorderUnited States
-
Chestnut Health SystemsHaymarket Center; Cook County Sheriff's Women's Justice ServicesCompletedRecovery Management Checkup (RMC) | Outcome MonitoringUnited States
-
Hospices Civils de LyonInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
-
Yale UniversityNational Institute of Mental Health (NIMH); VA Connecticut Healthcare SystemCompletedSchizophrenia | Bipolar Disorder | Dual DiagnosisUnited States
-
New York State Psychiatric InstituteEmory UniversityCompletedDepressive Disorder | Bipolar Disorder | Mental Disorders, Severe | Schizophrenia and Related Disorders
-
University Hospital, AkershusHelse Sor-Ost; RomeriksprosjektetCompletedMental Disorders | Mood Disorders | Schizophrenia | Bipolar Disorder | Affective Disorders, PsychoticNorway
-
Karolinska InstitutetDalarna County Council, SwedenActive, not recruitingPsychotic Disorders | Antisocial Personality Disorder | Substance Use Disorders | Forensic Psychology | Forensic NursingSweden
-
Dartmouth-Hitchcock Medical CenterPatient-Centered Outcomes Research InstituteCompletedChronic Disease | Mental IllnessUnited States
-
Dartmouth-Hitchcock Medical CenterPatient-Centered Outcomes Research InstituteRecruiting
-
The Affiliated Hospital of Qingdao UniversityCompleted